Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719785/
https://ncbi.nlm.nih.gov/pubmed/18261793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2007.12.017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares